fda approves semaglutide for cardiovascular risk reduction Navigating the New Frontier: FDA's Approval of Wegovy FDA Approves OZEMPIC (Semaglutide) to

2.8% for placebo, HR = 1.27 (127)]

It is important to understand that similar to diabetes and blood pressure medications, anti-obesity medications only work if taken chronically

Reconstitution steps: Allow vial to reach room temperature before opening Wipe rubber stopper with an alcohol swab and allow to dry Insert needle bevel-up at a 45 angle through the stopper Inject bacteriostatic water slowly along the glass wall, do not aim at the lyophilised cake Gently swirl until fully dissolved, do not vortex, shake, or sonicate Inspect for clarity and absence of particles before use Storage: Lyophilised vials (store at 20C, protected from light)

Differences between agents highlight the importance of individualized treatment strategies, complemented by nutritional and exercise interventions to optimize long-term outcomes

Advances in developing noncovalent small molecules targeting Keap1